PTPRC and carcinoma: Specifically, for patients RC01, RC02, RC03, R01, R02, R03, LC01, and LC02, a modified full‐length Smart‐seq2 method was used to study the composition of CD45+ cells isolated from tumors, ANT (proximal to the brim of carcinoma 3‐5 cm), and distinct normal tissues (DNT, distal to the brim of carcinoma >10 cm).